Pradeep Tyagi Selected Research

Cystitis

1/2022	Low energy shock wave therapy attenuates mitochondrial dysfunction and improves bladder function in HCl induced cystitis in rats.
11/2018	Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in mice.
8/2017	Effects of low energy shock wave therapy on inflammatory moleculars, bladder pain, and bladder function in a rat cystitis model.
1/2017	Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
11/2015	Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.
8/2015	Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation.
4/2015	Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis.
1/2014	Advances in Therapeutic Development for Radiation Cystitis.
3/2011	Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis.
9/2010	Urinary Nerve Growth Factor Levels in Urinary Tract Diseases With or Without Frequency Urgency Symptoms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pradeep Tyagi Research Topics

Disease

25	Inflammation (Inflammations) 01/2022 - 07/2006
24	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2021 - 07/2006
21	Overactive Urinary Bladder (Overactive Bladder) 10/2019 - 10/2008
14	Cystitis 01/2022 - 05/2004
12	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 10/2007
10	Pain (Aches) 10/2019 - 04/2007
8	Underactive Urinary Bladder 01/2022 - 01/2014
5	Ataxia (Dyssynergia) 01/2021 - 10/2007
5	Neoplasms (Cancer) 11/2018 - 11/2004
4	Prostatitis 10/2019 - 04/2007
3	Shock 09/2019 - 08/2016
3	Hypersensitivity (Allergy) 09/2019 - 01/2016
3	Lower Urinary Tract Symptoms 08/2018 - 01/2010
3	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2017 - 10/2007
3	Abnormal Reflex (Hyperreflexia) 04/2015 - 01/2004
3	Urinary Bladder Diseases (Bladder Diseases) 01/2014 - 05/2004
3	Urologic Diseases (Urinary Tract Disease) 04/2011 - 02/2010
3	Urinary Bladder Neoplasms (Bladder Cancer) 02/2010 - 07/2006
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 10/2019
2	Hyperplasia 01/2022 - 01/2015
2	Fibrosis (Cirrhosis) 11/2018 - 08/2017
2	Chronic Pain 08/2018 - 01/2016
2	Obesity 01/2018 - 07/2015
2	Hemorrhagic Cystitis 01/2014 - 04/2013
2	Prostatic Neoplasms (Prostate Cancer) 02/2010 - 11/2004
2	Wounds and Injuries (Trauma) 10/2007 - 06/2003
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Edema (Dropsy) 09/2019
1	Hyperalgesia 09/2019
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 11/2018
1	Diabetes Mellitus 08/2018
1	Osteoarthritis 08/2018
1	Mental Disorders (Mental Disorder) 08/2018
1	Endometriosis 01/2018
1	Urinary Retention 01/2018

Drug/Important Bio-Agent (IBA)

18	Nerve Growth Factor (NGF)IBA 12/2021 - 07/2006
9	Liposomes (Liposome)IBA 12/2021 - 11/2004
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2009
7	Pharmaceutical PreparationsIBA 01/2017 - 05/2004
7	CytokinesIBA 12/2016 - 02/2009
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015 - 05/2004
6	Therapeutic UsesIBA 12/2021 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2004
6	Messenger RNA (mRNA)IBA 01/2021 - 03/2015
6	Formaldehyde (Formol)FDA Link 01/2021 - 01/2014
6	Capsaicin (Zostrix)FDA Link 09/2019 - 01/2004
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2017
5	Type A Botulinum Toxins (Botox)FDA Link 10/2019 - 04/2007
5	ChemokinesIBA 01/2018 - 09/2010
4	Antisense OligonucleotidesIBA 12/2021 - 08/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2012
4	Botulinum Toxins (Botulinum Toxin)IBA 01/2017 - 01/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 09/2010
4	Tacrolimus (Prograf)FDA LinkGeneric 08/2015 - 03/2011
3	CollagenIBA 01/2022 - 08/2017
3	Muscarinic AntagonistsIBA 10/2020 - 09/2010
3	ProstaglandinsIBA 01/2018 - 12/2010
3	salicylhydroxamic acid (SHAM)IBA 01/2017 - 01/2015
3	Acetic Acid (Vinegar)FDA LinkGeneric 12/2016 - 01/2016
3	Dinoprostone (PGE2)FDA Link 01/2014 - 12/2010
3	mirabegronIBA 05/2013 - 10/2010
2	gadobutrolIBA 01/2020 - 03/2018
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2020 - 03/2018
2	incobotulinumtoxinA FDA Link 10/2019 - 04/2007
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 03/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 03/2015
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2017 - 10/2010
2	Analgesics (Analgesic Drugs)IBA 08/2017 - 04/2007
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2017 - 04/2015
2	OligonucleotidesIBA 01/2016 - 07/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 09/2010
2	AndrogensIBA 03/2015 - 04/2014
2	CannabinoidsIBA 01/2010 - 04/2009
2	LigandsIBA 10/2005 - 11/2004
1	IvabradineIBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Soluble Guanylyl CyclaseIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Heme (Haem)IBA 01/2022
1	Acid Sensing Ion ChannelsIBA 01/2021
1	Z 338IBA 10/2020
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	PotassiumIBA 01/2019
1	NitrogenIBA 11/2018
1	Oxygen (Dioxygen)IBA 11/2018
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2018
1	LM11A-31IBA 11/2018
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 11/2018
1	Nerve Growth Factors (Neurotrophins)IBA 08/2018
1	Immunomodulating AgentsIBA 05/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2018

Therapy/Procedure

24	Therapeutics 12/2021 - 01/2004
6	Extracorporeal Shockwave Therapy 01/2022 - 08/2017
3	Intravesical Administration 01/2017 - 01/2014
3	Drug Therapy (Chemotherapy) 01/2014 - 07/2006
2	Radiotherapy 11/2018 - 01/2014
2	Cystectomy 11/2018 - 01/2014
2	Lasers (Laser) 01/2017 - 04/2015